Parallel Advisors, LLC Bio Rad Laboratories, Inc. Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 449 shares of BIO stock, worth $153,337. This represents 0.0% of its overall portfolio holdings.

Number of Shares

449

Previous 402 11.69%

Holding current value

$153,337

Previous $109,000 37.61%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$263.97 - $344.64 $12,406 - $16,198	47 Added 11.69%	449 $150,000
Q2 2024 Aug 08, 2024	BUY	$268.26 - $339.48 $62,772 - $79,438	234 Added 139.29%	402 $109,000
Q1 2024 May 06, 2024	SELL	$304.11 - $351.99 $912 - $1,055	-3 Reduced 1.75%	168 $58,000
Q4 2023 Feb 09, 2024	BUY	$269.37 - $365.04 $12,391 - $16,791	46 Added 36.8%	171 $55,000
Q3 2023 May 20, 2024	BUY	$350.25 - $422.63 $4,553 - $5,494	13 Added 11.61%	125 $44,000
Q3 2023 Nov 13, 2023	BUY	$350.25 - $422.63 $4,553 - $5,494	13 Added 11.61%	125 $44,000
Q2 2023 May 20, 2024	SELL	$359.49 - $486.4 $3,954 - $5,350	-11 Reduced 8.94%	112 $42,000
Q2 2023 Aug 04, 2023	SELL	$359.49 - $486.4 $3,954 - $5,350	-11 Reduced 8.94%	112 $42,000
Q1 2023 May 20, 2024	SELL	$418.69 - $503.0 $18,841 - $22,635	-45 Reduced 26.79%	123 $58,000
Q1 2023 Apr 25, 2023	SELL	$418.69 - $503.0 $837 - $1,006	-2 Reduced 1.6%	123 $58,000
Q4 2022 Feb 03, 2023	SELL	$351.71 - $456.01 $24,971 - $32,376	-71 Reduced 36.22%	125 $52,000
Q3 2022 Nov 10, 2022	SELL	$412.59 - $563.26 $71,378 - $97,443	-173 Reduced 46.88%	196 $82,000
Q2 2022 Aug 01, 2022	SELL	$463.67 - $597.16 $76,969 - $99,128	-166 Reduced 31.03%	369 $183,000
Q1 2022 Apr 28, 2022	SELL	$524.57 - $735.42 $97,045 - $136,052	-185 Reduced 25.69%	535 $310,000
Q4 2021 Jan 20, 2022	BUY	$708.84 - $794.68 $37,568 - $42,118	53 Added 7.95%	720 $544,000
Q3 2021 Nov 02, 2021	BUY	$657.71 - $825.77 $44,724 - $56,152	68 Added 11.35%	667 $498,000
Q2 2021 Aug 06, 2021	SELL	$576.64 - $649.04 $5,766 - $6,490	-10 Reduced 1.64%	599 $386,000
Q1 2021 Apr 23, 2021	SELL	$547.01 - $662.35 $5,470 - $6,623	-10 Reduced 1.62%	609 $348,000
Q4 2020 Feb 02, 2021	BUY	$510.68 - $643.45 $27,576 - $34,746	54 Added 9.56%	619 $361,000
Q3 2020 Oct 27, 2020	BUY	$454.43 - $535.6 $22,721 - $26,780	50 Added 9.71%	565 $291,000
Q2 2020 Jul 16, 2020	BUY	$334.87 - $493.06 $31,142 - $45,854	93 Added 22.04%	515 $232,000
Q1 2020 Apr 27, 2020	BUY	$320.01 - $409.07 $78,082 - $99,813	244 Added 137.08%	422 $147,000
Q3 2019 Nov 01, 2019	SELL	$304.55 - $345.24 $3,959 - $4,488	-13 Reduced 6.81%	178 $59,000
Q1 2019 May 01, 2019	BUY	$224.3 - $317.41 $2,691 - $3,808	12 Added 6.7%	191 $58,000
Q4 2018 Feb 05, 2019	BUY	$220.1 - $309.0 $2,641 - $3,708	12 Added 7.19%	179 $41,000
Q3 2017 Nov 15, 2017	BUY	$212.27 - $242.28 $35,449 - $40,460	167 New	167 $42,000
Q3 2017 Nov 14, 2017	SELL	$212.27 - $242.28 $39,057 - $44,579	-184 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	184	184 $43,000

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Bio Rad Laboratories, Inc. Transaction History